Prof. Dr. med. Arndt Hartmann

Lehrstuhl für Allgemeine Pathologie und Pathologische Anatomie

TERT promoter mutation analysis as a surrogate to morphology and immunohistochemistry in problematic spindle cell lesions of the urinary bladder (2020) Bertz S, Stöhr R, Gaisa NT, Wullich B, Hartmann A, Agaimy A Journal article Assessment of the additional clinical potential of X-ray dark-field imaging for breast cancer in a preclinical setup (2020) Emons J, Fasching P, Wunderle M, Heindl F, Rieger J, Horn F, Pelzer G, et al. Journal article Mass Spectrometry Imaging Differentiates Chromophobe Renal Cell Carcinoma and Renal Oncocytoma with High Accuracy (2020) Kriegsmann M, Casadonte R, Maurer N, Stoehr C, Erlmeier F, Moch H, Junker K, et al. Journal article Impact of fibroblast growth factor receptor 1 (FGFR1) amplification on the prognosis of breast cancer patients (2020) Erber R, Rübner M, Davenport S, Hauke S, Beckmann M, Hartmann A, Häberle L, et al. Journal article Characterization of PD-1 and PD-L1 Expression in Papillary Renal Cell Carcinoma: Results of a Large Multicenter Study (2020) Erlmeier F, Steffens S, Stöhr C, Herrmann E, Polifka I, Agaimy A, Trojan L, et al. Journal article Transurethral en bloc submucosal hydrodissection vs conventional resection for resection of non-muscle-invasive bladder cancer (HYBRIDBLUE): a randomised, multicentre trial (2020) Gakis G, Karl A, Bertz S, Burger M, Fritsche HM, Hartmann A, Jokisch F, et al. Journal article Molecular differences between arterial and venous grafts in the first year after coronary artery bypass grafting (2020) Steger CM, Hartmann A, Rieker R Journal article Histology of Luminal Breast Cancer (2020) Erber R, Hartmann A Journal article, Review article FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment? (2020) van Rhijn BW, Mertens LS, Mayr R, Bostrom PJ, Real FX, Zwarthoff EC, Boormans JL, et al. Journal article Influence of Family History of Breast or Ovarian Cancer on Pathological Complete Response and Long-Term Prognosis in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy (2020) Wunderle M, Häberle L, Hein A, Jud S, Lux MP, Hack C, Emons J, et al. Journal article